Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.80% | -16.06% | -19.19% | 30.86% | 17.03% |
| Total Depreciation and Amortization | -6.20% | -3.68% | -5.09% | -18.15% | 17.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | 9.40% | -- |
| Total Other Non-Cash Items | -276.38% | -70.47% | -281.30% | -275.00% | 243.33% |
| Change in Net Operating Assets | 111.20% | 118.35% | 249.02% | -2,811.11% | -160.39% |
| Cash from Operations | 11.63% | -6.86% | 325.96% | -88.10% | -57.60% |
| Capital Expenditure | 25.83% | -7.49% | -19.90% | 9.01% | -8.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -400.00% | -100.00% | 25.00% | 100.90% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.50% | 194.89% | -578.64% | -69.90% | -1,153.62% |
| Cash from Investing | -62.34% | 123.14% | -1,694.17% | 128.33% | -205.24% |
| Total Debt Issued | -90.65% | -126.82% | 24.04% | -69.09% | 7,275.00% |
| Total Debt Repaid | 157.05% | -876.36% | -50.33% | 62.65% | -264.44% |
| Issuance of Common Stock | -- | -- | 60.87% | 262.50% | -100.00% |
| Repurchase of Common Stock | 61.82% | 20.88% | -15.45% | 73.98% | -1,213.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.10% | 3.12% | 2.59% | -1.07% | -0.79% |
| Other Financing Activities | -76.19% | 300.00% | 78.57% | 271.43% | 2,000.00% |
| Cash from Financing | 244.86% | -385.06% | -31.74% | -83.24% | 126.56% |
| Foreign Exchange rate Adjustments | -100.00% | -400.00% | -1,000.00% | 25.00% | -114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.18% | -45.75% | 121.07% | 84.36% | -88.82% |